Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on January 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Immunology and Hereditary Autoinflammatory Diseases Scientist

Closed
75N94026Q00028Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 16 hours ago

DEADLINE

in 11 months
NAICS: 541715
New
Grant
Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Solicitation # RFA-DC-28-002
Solicitation RFA-DC-28-002 is a Notice of Funding Opportunity from the National Institutes of Health, specifically the National Institute on Deafness and Other Communication Disorders, to establish a Coordinating Center for the NIDCD National Human Ear Resource Network. This collaborative network provides human inner and middle ear tissues to researchers for basic and clinical studies aimed at advancing the treatment of auditory and vestibular disorders. The Coordinating Center is responsible for maintaining network cohesiveness through the planning of workshops, symposia, and regular meetings, providing updates to laboratories, and managing communication with the public and scientific community regarding tissue donation. The maximum project period is five years, with a budget limit of 200,000 dollars in direct costs per year. Applicants, including for-profit organizations and small businesses, must maintain active registrations in SAM, eRA Commons, and Grants.gov. Proposals are evaluated based on the significance of the proposed center and the qualifications of the investigators, with additional reviews for human subject protections, inclusion policies, and the use of vertebrate animals. Key requirements include a structured Data Management and Sharing Plan and adherence to cybersecurity guidelines, including a 48-hour incident reporting window. The application process is entirely electronic and requires several standard PHS and SF424 forms, with a response deadline of March 5, 2027.
National Institutes Of Health

POSTED

about 24 hours ago

DEADLINE

in 5 months
NAICS: 541715
New
Grant
National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Solicitation # RFA-DC-28-001
Solicitation RFA-DC-28-001 is a Notice of Funding Opportunity issued by the National Institutes of Health under the Department of Health and Human Services to support the NIDCD National Human Ear Resource Network. The objective is to maintain a collaborative network of laboratories that serve as a national technological resource, providing human inner and middle ear tissues to researchers for basic and clinical studies to advance the treatment of auditory and vestibular disorders. The scope of work includes processing human temporal bones from the National Hearing and Balance Organ Donor Program, uploading images and medical data to EarBase, sharing gene-expression data via the gEAR repository, and providing technical instruction to increase the number of skilled researchers in the field. The NIDCD intends to commit 3.6 million dollars in FY 2028 to fund up to six awards, with a maximum project period of five years. Individual awards are limited to 450,000 dollars in direct costs per year, with an additional 150,000 dollars available for specific subawards. Applications are due on March 05, 2027, and November 01, 2027, with staggered start dates ranging from July 2027 to July 2028. Evaluation is based on the experience of the investigators, the adequacy of the institutional environment, and the protection of human subjects. Applicants must maintain active SAM registration and a Unique Entity Identifier, and they must provide a Data Management and Sharing Plan and a Material Transfer Agreement. Compliance with the Cybersecurity Act of 2015 is required, including the development of an incident response plan and notification of cybersecurity incidents within 48 hours of discovery.
National Institutes Of Health

POSTED

about 24 hours ago

DEADLINE

in about 1 year

General Info

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

MD, USA

Set-Aside

SBA

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nichd
Contacts1 person available
OfficeBETHESDA, MD, 20817, USA
Office AddressBETHESDA, MD, 20817, USA
Contacts
Kimesha Leake

Full Description

Show more

INTRODUCTION


THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). 



The National Institute of Child Health and Human Development (NICHD), Office of Acquisitions (OA) on behalf of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to award a purchase order without providing for full and open competition for Immunology and Hereditary Autoinflammatory Diseases Scientist from Edwan LLC.


NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE


The intended procurement is classified under NAICS code 541715 with a Size Standard of 1000 employees.



REGULATORY AUTHORITY


The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2025-06 effective October 1, 2025.



This acquisition is conducted under the procedures as prescribed in FAR Subpart 13.106-1(b).



STATUTORY AUTHORITY


This acquisition is conducted under the authority of 41 U.S.C. 1901 – Simplified Acquisition Procedures.



DESCRIPTION OF REQUIREMENT



BACKGROUND



The Biomedical and Metabolic Imaging Branch (BMIB) focuses on developing noninvasive imaging approaches with high spatial (micro-millimeter) and temporal (milliseconds) resolution that allow multi-organ evaluation and analysis to better understand the interplay between atherogenesis and metabolic syndrome in humans. Patients with rare genetic mutations such as hyper immunoglobulin E (Job's) syndrome (immune system and coronary arteries), Turner's syndrome (genetics and vascular disease), lipodystrophy (metabolic dysfunction and cardiovascular disease), or HIV infection (inflammation and coronary disease), share many of the metabolic and immunological dysregulations encountered in multi-organ disease subjects inclusive of atherogenesis.  The goal has been to isolate and understand the effects of these defects and the early events that signal atherosclerosis.



In order to accomplish the goals of this program, The National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), BMIB has a requirement to obtain services of a scientist with extensive expertise in innate immunology and hereditary autoinflammatory diseases with demonstrated understanding of, and ability to apply principles, concepts, practices and standards associated with patient sample testing in a laboratory setting. The scientist must demonstrate experience and understanding of techniques directly applicable to the Biomedical and Metabolic Imaging Branch research (tissue culture, molecular and cellular biological techniques such as PCR, flow cytometry, IHC, etc.) and must be self-motivated and driven to achieve milestones and exceed goals with minimal direction. Furthermore, they must possess a PhD with 15+ years of demonstrated expertise in immunology and/or inflammation research.



CONTRACTOR REQUIREMENTS



The contractor must have:


  • PhD with 15+ years of directly relevant experience in immunology, or inflammation.
  • Proficiency in T cell culture, multicolor Flow Cytometry, RNA-seq, western blotting, q-PCR, multiplex ELISA, mRNA isolation, T cell isolation, cell assay development, mouse handling/ organ isolation is required.
  • Expertise in lentiviral production, synthetic biology, lentiviral vector design desired.
  • Expertise in exosome purification and characterization. 
  • Knowledge of standard Human T cell isolation & in vitro culture techniques is required.
  • Possess experience using autoimmune and inflammatory disease mouse and rabbit models.
  • Good understanding of immune signaling pathways and interest in metabolomics.
  • Ability to contribute creatively and strategically to in vitro assay design, optimization and derive actionable biological conclusions.
  • Ability to define and implement critical studies needed to support hypothesis-based research.
  • Ability to write protocols and study reports, produce and maintain accurate records.
  • Expertise with data analysis software such as Excel and Graphpad Prism
  • Strong verbal and written communication skills.
  • Ability to synthesize complex scientific problems into a strategy and tactics.
  • Familiarity with both Microsoft and Mac operating systems, including PowerPoint, Excel, Word, Adobe Photoshop and Access.
  • Excellent interpersonal, analytical, organizational and time management skills.


The contractor shall deliver scientific data and results and implement the following:


  • Tissue processing and purification of immune cells, in vitro cell based bioassay development, tissue cell culture (primary mouse and human cells and cell lines)
  • Multicolor flow cytometry (FACS), and ELISA assays
  • Basic molecular biology techniques (cloning, viral tranductions, etc.)
  • Analyze biological data using FlowJo, Microsoft Excel, and GraphPad Prism
  • Interpret, analyze and present data; work in fast-paced, result oriented research environment
  • Contribute to project advancement by developing new methods or technologies and troubleshooting existing protocol
  • Write protocols and study reports, produce and maintain accurate records
  • Prepare manuscripts for journal publications

The contractor shall:


  • Drive discovery and translational research aimed at identifying, characterizing, and interpreting results for novel diagnosis for inflammatory diseases. The candidate must be able to create their own research plans with minimum support from the principal investigator. The candidate must be able to run research plans independently. Weekly/as needed meetings shall be held to evaluate the work and provide directions for next steps.


  • Define and implement critical studies needed to support hypothesis-based research. The candidate’s progress shall be parodically evaluated and the candidate shall be provided with feedback and directions.


  • Make contributions to scientific literature and conferences through publication and presentation of research results. The candidate shall be evaluated based on preparing manuscripts and abstracts for scientific publications.


  • Identify and evaluate a wide variety of in vitro assays to test immunological, metabolic, and various disease mechanisms.


  • Contribute creatively and strategically to in vitro assay design, optimization, and derive actionable biological conclusions.


  • Perform assay development, qualification and validations as needed.


  • Conduct cell-based assays including, but not limited to, ELISA and Flow Cytometry.


  • Separate, isolate and cryopreserve primary cells peripheral blood mononuclear cells (PBMCs).


  • Organize data prior to scientific publication submission. The data shall be reviewed and evaluated by the principal investigator. 


  • Ensure lab maintenance activities and equipment calibration are performed according to schedule.


  • Ensure lab maintenance activities and maintain a clean and safe lab environment.


ORDER TYPE



This purchase order will be a firm fixed price.



PERIOD OF PERFORMANCE AND PAYMENT BREAKDOWN



The period of performance for this order is:



Base period:        1/20/2026 to 1/19/2027


Option period 1: 1/20/2027 to 1/19/2028



Payment shall be made monthly in arrears.



The contractor shall work 40 hours per week, Monday through Friday, totaling 2080 hours per year.



CLOSING STATEMENT



Extensive expertise in innate immunology and hereditary autoinflammatory diseases is vital to the study of the relationship between atherosclerosis and obesity and other metabolic disorders. This is an ongoing project, with several ongoing experiments. All of these experiments are highly complex in nature and require great attention to technical details.    


Edwan LLC possesses extensive expertise in innate immunology and hereditary autoinflammatory diseases, which is vital to the study of the relationship between atherosclerosis and obesity and other metabolic disorders. The Biomedical and Metabolic Imaging Branch has been unable to locate on the market other vendors with this expertise and knowledge. In addition, this is an ongoing project that requires specific knowledge of the history of the development of each experiment and the thought process that led to each conclusion. Thus, these unique capabilities can’t be easily replicated in other vendors.


This is not a request for competitive proposals.  However, interested parties may identify their interest and capability to respond to this notice.  Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.



A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.  The information received will be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.  



All responses must be received by Tuesday, January 13, 2026 at 12:00 PM EST. Responses must be submitted via email to Kimesha Leake, Contracting Officer at Kimesha.leake@nih.gov   



All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.



More opportunities from Department Of Health And Human Services → National Institutes Of Health Nichd

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS